The Fund supports networks of state health policy decision makers to help identify, inspire, and inform policy leaders.
The Milbank Memorial Fund supports two state leadership programs for legislative and executive branch state government officials committed to improving population health.
The Fund identifies and shares policy ideas and analysis to advance state health leadership, strong primary care, and sustainable health care costs.
Keep up with news and updates from the Milbank Memorial Fund. And read the latest blogs from our thought leaders, including Fund President Christopher F. Koller.
The Fund publishes The Milbank Quarterly, as well as reports, issues briefs, and case studies on topics important to health policy leaders.
The Milbank Memorial Fund is is a foundation that works to improve population health and health equity.
December 19, 2023
Feb 13, 2024
Nov 20, 2023
Oct 3, 2023
Back to Articles and Updates
Even after accounting for rebates, prescription drug spending has continued to grow at an unaffordable rate, according to a new analysis of three states with health care cost growth targets—Connecticut, Rhode Island, and Oregon—published in Health Affairs Forefront. As part of their efforts to implement health care cost growth targets, these states now require payers to provide aggregate data on pharmaceutical rebates they receive.
In the article, Jessica Mar and January Angeles of Bailit Health explain that pharmaceutical manufacturers often tout that drug rebates — or discounts of usually undisclosed amounts given to health insurers and pharmacy benefit managers — significantly lower prescription drug prices and price growth.
Using aggregate spending data, the three states calculated actual spending on prescription drugs between 2018 and 2021. While rebates reduced drug spending growth, spending still increased by between 3.2% and 6.1%. This trend exceeded growth in Connecticut and Rhode Island’s median household income. Oregon’s trend post-rebate was slightly lower than its household income growth.
These states receive technical assistance with their health care cost growth programs through the Peterson–Milbank Program for Sustainable Health Care Costs.
Get the Latest from the Milbank Memorial Fund
An endowed operating foundation that engages in nonpartisan analysis, collaboration, and communication, with an emphasis on state health policy.